Literature DB >> 6805839

Inappropriate secretion of antidiuretic hormone treated with frusemide.

G Decaux, Y Waterlot, F Genette, R Hallemans, J C Demanet.   

Abstract

Seven out of nine patients with chronic inappropriate secretion of antidiuretic hormone were successfully treated with 40 mg frusemide daily. One patient needed 80 mg, and the remaining patient achieved only a small increase in diuresis after 40 mg frusemide; this was probably related to his low creatinine clearance. In order to maintain a salt intake high enough to compensate for the loss of urine electrolytes 3 to 6 g sodium chloride was added as tablets to the sodium-free diet in six patients. Hypokalaemia occurred in five patients but was easily corrected with either supplements of potassium chloride or a potassium-sparing diuretic. These findings add further weight to evidence that Frusemide is a good alternative for the treatment of patients with inappropriate secretion of antidiuretic hormone who cannot tolerate water restriction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805839      PMCID: PMC1498910          DOI: 10.1136/bmj.285.6335.89

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Correction of antidiuresis by demeclocycline.

Authors:  A De Troyer; J C Demanet
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

Review 2.  The syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  F C Bartter; W B Schwartz
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

3.  Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide.

Authors:  G Decaux; Y Waterlot; F Genette; J Mockel
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

4.  Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.

Authors:  G Decaux; J Unger; S Brimioulle; J Mockel
Journal:  JAMA       Date:  1982 Jan 22-29       Impact factor: 56.272

5.  Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  G Decaux; F Genette
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24
  5 in total
  9 in total

Review 1.  Thick ascending limb of the loop of Henle.

Authors:  David B Mount
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 2.  Cerebral ventricular volume during hyponatraemia.

Authors:  G Decaux; M Szyper; A Grivegnée
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

Review 3.  Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management.

Authors:  Helbert Rondon-Berrios; Tomas Berl
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-24       Impact factor: 8.237

4.  Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin.

Authors:  F A László; C Varga; T Dóczi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Lack of efficacy of phenytoin in the syndrome of inappropriate anti-diuretic hormone secretion of neurological origin.

Authors:  G Decaux; S Przedborski; A Soupart
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

6.  Hyponatraemia associated with pneumonia or bacterial meningitis.

Authors:  F Shann; S Germer
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

7.  Metabolic effects of prostatectomy.

Authors:  P A Hamilton Stewart; I M Barlow
Journal:  J R Soc Med       Date:  1989-12       Impact factor: 18.000

8.  SIADH Induced by Pharyngeal Squamous Cell Carcinoma: Case Report and Literature Review.

Authors:  Hafiz Muhammad Sharjeel Arshad; Aleida Rodriguez; Faten Suhail
Journal:  Case Rep Nephrol       Date:  2016-08-22

9.  Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.

Authors:  Michele Umbrello; Elena S Mantovani; Paolo Formenti; Claudia Casiraghi; Davide Ottolina; Martina Taverna; Angelo Pezzi; Giovanni Mistraletti; Gaetano Iapichino
Journal:  Ann Intensive Care       Date:  2016-01-04       Impact factor: 6.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.